Prognostic impact of local treatment against postoperative oligometastases in non-small cell lung cancer

Impact of Epidermal Growth Factor Receptor and KRAS Mutations on Clinical Outcomes in Previously Untreated Non-Small Cell Lung Cancer Patients: Results of an Online Tumor Registry of Clinical Trials

(2009) D. M. Jackman et al.   CLINICAL CANCER RESEARCH

Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer

(2009) Rafael Rosell et al.   NEW ENGLAND JOURNAL OF MEDICINE

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

(2009) Tony S. Mok et al.   NEW ENGLAND JOURNAL OF MEDICINE

Current status of pulmonary metastasectomy from primary epithelial tumors

(2009) Tokujiro Yano et al.   SURGERY TODAY

Never-smoking nonsmall cell lung cancer as a separate entity

(2008) Tokujiro Yano et al.   CANCER

A rationale for the targeted treatment of oligometastases with radiotherapy

(2008) Dhara M. MacDermed et al.   JOURNAL OF SURGICAL ONCOLOGY

Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial

(2008) Edward S Kim et al.   LANCET